135 related articles for article (PubMed ID: 9805656)
1. Recognition of HLA-DR1/DRB1*0101 molecules presenting HLA-A2 derived peptides by a human recombinant antibody, Fab-5 A1.
Löffler D; Welschof M; Goldmann SF; Wölpl A
Eur J Immunogenet; 1998 Oct; 25(5):339-47. PubMed ID: 9805656
[TBL] [Abstract][Full Text] [Related]
2. Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells.
Wölpl A; Halder T; Kalbacher H; Neumeyer H; Siemoneit K; Goldmann SF; Eiermann TH
Tissue Antigens; 1998 Mar; 51(3):258-69. PubMed ID: 9550326
[TBL] [Abstract][Full Text] [Related]
3. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
[TBL] [Abstract][Full Text] [Related]
4. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody with specificity to the HLA-DR1 and -DR51 antigens.
Loh MT; Chan SH; Ren EC
Tissue Antigens; 1993 Aug; 42(2):100-4. PubMed ID: 8266318
[TBL] [Abstract][Full Text] [Related]
6. Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background.
Knapp B; Fischer G; Van Hemelen D; Fae I; Maillere B; Ebner C; Schreiner W; Bohle B; Jahn-Schmid B
BMC Immunol; 2012 Aug; 13():43. PubMed ID: 22871092
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.
Baier G; Baier-Bitterlich G; Looney DJ; Altman A
J Virol; 1995 Apr; 69(4):2357-65. PubMed ID: 7533857
[TBL] [Abstract][Full Text] [Related]
8. Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.
Johnson LE; McNeel DG
Prostate; 2012 May; 72(7):730-40. PubMed ID: 22529020
[TBL] [Abstract][Full Text] [Related]
9. Mapping of an HLA-DRw52-associated determinant on DR beta 1 molecules.
Ballas M; Eiermann TH; Wölpl A; Goldmann SF
Tissue Antigens; 1990 Nov; 36(5):187-93. PubMed ID: 1710076
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
11. 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model.
Knapp B; Omasits U; Bohle B; Maillere B; Ebner C; Schreiner W; Jahn-Schmid B
Mol Immunol; 2009 May; 46(8-9):1839-44. PubMed ID: 19232439
[TBL] [Abstract][Full Text] [Related]
12. Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.
BenMohamed L; Krishnan R; Longmate J; Auge C; Low L; Primus J; Diamond DJ
Hum Immunol; 2000 Aug; 61(8):764-79. PubMed ID: 10980387
[TBL] [Abstract][Full Text] [Related]
13. Indirect allorecognition of HLA class I peptides by CD4+ cytolytic T lymphocytes.
Susskind B; Iannotti MR; Shornick MD; Steward NS; Gorka J; Mohanakumar T
Hum Immunol; 1996 Mar; 46(1):1-9. PubMed ID: 9157083
[TBL] [Abstract][Full Text] [Related]
14. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.
Chames P; Hufton SE; Coulie PG; Uchanska-Ziegler B; Hoogenboom HR
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7969-74. PubMed ID: 10884427
[TBL] [Abstract][Full Text] [Related]
15. Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity.
Frasca L; Tamir A; Jurcevic S; Marinari B; Monizio A; Sorrentino R; Carbonari M; Piccolella E; Lechler RI; Lombardi G
Transplantation; 2000 Aug; 70(4):631-40. PubMed ID: 10972222
[TBL] [Abstract][Full Text] [Related]
16. Peptide microarray-based identification of Mycobacterium tuberculosis epitope binding to HLA-DRB1*0101, DRB1*1501, and DRB1*0401.
Gaseitsiwe S; Valentini D; Mahdavifar S; Reilly M; Ehrnst A; Maeurer M
Clin Vaccine Immunol; 2010 Jan; 17(1):168-75. PubMed ID: 19864486
[TBL] [Abstract][Full Text] [Related]
17. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes.
Ogg GS; Dunbar PR; Cerundolo V; McMichael AJ; Lemoine NR; Savage P
Br J Cancer; 2000 Mar; 82(5):1058-62. PubMed ID: 10737389
[TBL] [Abstract][Full Text] [Related]
19. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
20. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
Papassavas AC; Barnardo MC; Bunce M; Welsh KI
Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
